Tilray Backs First Human Study On Medical Marijuana Used For Breast Cancer Drug Side EffectsBenzinga • 10/24/19
Marijuana Stock Tilray Is Ramping Up Its CBD Partnership With Anheuser-Busch InBevThe Motley Fool • 10/13/19
Marijuana Stocks: Pot Producers' Price Targets Slashed After Six Months Of Bad NewsInvestors Business Daily • 10/11/19
Marijuana's "Big Four" Lost Nearly $14 Billion in Value During the Third QuarterThe Motley Fool • 10/07/19